DEVICE DEVELOPMENT AND SUPPLY AGREEMENTDevice Development and Supply Agreement • March 20th, 2023 • Liquidia Corp • Pharmaceutical preparations
Contract Type FiledMarch 20th, 2023 Company IndustryThis Device Development and Supply Agreement (“Agreement”) is made this 1st day of December, 2022 by and among Mainbridge Health Partners, LLC, with its principal place of business at 30399 North Chardon Lane; Grayslake IL 60030, (“Mainbridge”), Liquidia PAH, LLC, with its principal place of business at 419 Davis Drive, Suite 100, Morrisville, NC 27560 (“Liquidia”) and Sandoz Inc., with its principal place of business at 100 College Road West, Princeton, NJ, 08540 (“Sandoz” and, collectively with Mainbridge and Liquidia, the “Parties” and each a “Party”).